EXCEL LONDON 
20-21 NOVEMBER 2025

Portfolio Events
Loading

Anal sac adenocarcinomas are not necessarily a pain in the bxxx- Practical case discussions

14 Nov 2024
Gallery Suite 15-16
Oncology
Delivered by:
Anal sac adenocarcinomas are not necessarily a pain in the bxxx- Practical case discussions

Anal sac adenocarcinoma (AGASAC) is an uncommon tumour in the dog and comprises approximately 17% of perianal malignancies; however, it is one of the most common causes of paraneoplastic hypercalcemia. Clinical signs in affected dogs most commonly are associated with mechanical obstruction caused by the primary tumour or enlarged regional metastatic lymph nodes and the effects of paraneoplastic hypercalcemia when present. Surgical excision of the primary tumour and metastasectomy of affected locoregional lymph nodes is the preferred initial treatment option for most dogs, although radiation therapy and adjuvant chemotherapy are commonly incorporated into multi-modality treatment plans. Prolonged survival times are possible, especially for dogs with smaller primary tumours and for dogs that undergo further treatments for recurrent disease.

In this lecture, we will discuss the clinical signs, diagnosis, staging, treatment, and prognosis of AGASAC in the dog

Learning Outcomes
Canine anal sac tumor can be treated!! We will discuss prognostic indicators We will discuss different treatment options
Speakers
Gillian Dank, Veterinary Oncologist - HT-Vet
World-Renowned

Global Portfolio

BVA Live

12-13 June 2025

Deutsche Vet

16-17 May 2025

Singapore Vet

24-25 October 2025

Wild West Vet

15-18 October 2025

New York Vet

6-7 November 2025

Be the leader of your pack

Be the first to hear the latest news, programme updates and exclusive industry releases.

 

Education Partner

Platinum Sponsor

Gold Sponsor

Silver Sponsor

Media Sponsors